---
title: "OMEGA THERAPEUTICS INC (OMGAQ.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/OMGAQ.US/norm.md"
symbol: "OMGAQ.US"
name: "OMEGA THERAPEUTICS INC"
parent: "https://longbridge.com/en/quote/OMGAQ.US.md"
datetime: "2026-03-05T03:53:07.938Z"
locales:
  - [en](https://longbridge.com/en/quote/OMGAQ.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/OMGAQ.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/OMGAQ.US/norm.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/OMGAQ.US/norm.md) | [繁體中文](https://longbridge.com/zh-HK/quote/OMGAQ.US/norm.md)


# OMEGA THERAPEUTICS INC (OMGAQ.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
| --- | --- | --- | --- | --- | --- |
| EPS | -0.2981 | -0.3000 | -0.3650 | -0.3666 | -0.4035 |
| ROE | -347.97% | -192.91% | -162.05% | -120.63% | -103.50% |
| Revenue | 2.61M | 2.13M | 2.36M | 989000.00 | 831000.00 |
| Net income | -16.44M | -16.30M | -20.13M | -20.21M | -22.25M |

## Balance Sheet (USD)

| Indicator | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
| --- | --- | --- | --- | --- | --- |
| A&L | 152.73M | 168.22M | 183.68M | 204.37M | 217.81M |
| Leverage | 13.23 | 6.41 | 4.44 | 3.52 | 2.86 |
| BVPS | 0.2093 | 0.4761 | 0.7498 | 1.05 | 1.38 |
| Turnover | 0.0437 | 0.0318 | 0.0290 | 0.0177 | 0.0146 |

## Cash Flow Statement (USD)

| Indicator | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | -14.02M | -12.67M | -11.80M | -17.09M | -23.04M |
| Investing CF | -16000.00 | -396000.00 | 4.46M | 2.14M | -724000.00 |
| Financing CF | -1.44M | -1.11M | -1.07M | 1.63M | -8000.00 |
| Free CF | -5.28M | -7.26M | -5.29M | -12.73M | -15.46M |